|
FeNO在检测COPD和哮喘-COPD (ACO)的研究进展
|
Abstract:
呼出气一氧化氮(FeNO)是近年来发展起来的一项新的定量、非侵入性、简便安全的气道炎症检测技术,已被广泛用于临床检测以嗜酸性粒细胞浸润为主的气道炎症,反映气道炎症状态以及预测对激素治疗的反应性等。因其与嗜酸粒细胞气道炎症密切相关而广泛用于支气管哮喘研究,值得关注的是,近年研究发现,FeNO与COPD和ACO患者的慢性气道炎症相关,他们之间最大的共同点就是存在不同程度的气道炎症,虽然已开展了一些初步研究,但现有研究结论存在诸多争议和冲突,探究FeNO检测在气道炎症性疾病中的作用可能是未来研究趋势。
Exhaled nitric oxide (FeNO) is a new quantitative, non-invasive, simple and safe airway inflamma-tion detection technique developed in recent years, which has been widely used in clinical detection of airway inflammation mainly characterized by eosinophil infiltration, reflecting the status of air-way inflammation and predicting the responsiveness to hormone therapy. It is widely used in bronchial asthma studies due to its close correlation with eosinophilic airway inflammation. It is noteworthy that FeNO has been found in recent years to be associated with chronic airway inflam-mation in COPD and ACO patients. The biggest common point between FENO and ACO patients is the existence of airway inflammation to varying degrees. However, there are many disputes and con-flicts in the existing research conclusions, so it may be a future research trend to explore the role of FeNO detection in airway inflammatory diseases.
[1] | Celli, B.R. and Wedzicha, J.A. (2019) Update on Clinical Aspects of Chronic Obstructive Pulmonary Disease. The New England Journal of Medicine, 381, 1257-1266. https://doi.org/10.1056/NEJMra1900500 |
[2] | Agusti, A., Vogel-meier, C. and Faner, R. (2020) COPD 2020: Changes and Challenges. American Journal of Physiology-Lung Cellular and Molecular Physiology, 319, L879-L883. https://doi.org/10.1152/ajplung.00429.2020 |
[3] | Negewo, N.A., Gibson, P.G. and McDonald, V.M. (2015) COPD and Its Comorbidities: Impact, Measurement and Mechanisms. Respirology, 20, 1160-1171. https://doi.org/10.1111/resp.12642 |
[4] | Lopez-Campos, J.L., Tan, W. and Soriano, J.B. (2016) Global Burden of COPD. Respirology, 21, 14-23.
https://doi.org/10.1111/resp.12660 |
[5] | Zhang, K., Liang, Y., Feng, Y., et al. (2018) Decreased Epithelial and Sputum miR-221-3p Associates with Airway Eosinophilic Inflammation and CXCL17 Expression in Asthma. American Journal of Physiology-Lung Cellular and Molecular Physiology, 315, L253-L264. https://doi.org/10.1152/ajplung.00567.2017 |
[6] | Pavlidis, S., Takahashi, K., Ng, K.K.F., et al. (2019) “T2-High” in Severe Asthma Related to Blood Eosinophil, Exhaled Nitric Oxide and Serum Periostin. European Respiratory Journal, 53, Article ID: 1800938.
https://doi.org/10.1183/13993003.00938-2018 |
[7] | 范龙梅, 张威, 张明月, 等. 呼出气一氧化氮和肺泡一氧化氮在哮喘-慢性阻塞性肺疾病重叠诊断中的应用价值[J]. 北京医学, 2022, 44(9): 799-803. |
[8] | Bateman, E.D., Hurd, S.S., Barnes, P.J., et al. (2008) Global Strategy for Asthma Management and Prevention: GINA Executive Sum-mary. European Respiratory Journal, 31, 143-178. https://doi.org/10.1183/09031936.00138707 |
[9] | Kalemci, S., Sarihan, A. and Zeybek, A. (2020) Is Asthma and COPD Overlap Syndrome Weather and Environment Sensitive? Lung, 198, 241-242. https://doi.org/10.1007/s00408-019-00296-3 |
[10] | Mostafavi-Pour-Manshadi, S.M.Y., Naderi, N., Barrecheguren, M., et al. (2017) Investigating Fractional Exhaled Nitric Oxide (FeNO) in Chronic Obstructive Pulmo-nary Disease (COPD) and Asthma-COPD Overlap (ACO): A Scoping Review Protocol. BMJ Open, 7, e18954. https://doi.org/10.1136/bmjopen-2017-018954 |
[11] | Plaza, V., Alvarez, F., Calle, M., et al. (2017) Consensus on the Asthma-COPD Overlap Syndrome (ACOS) between the Spanish COPD Guidelines (GesEPOC) and the Spanish Guidelines on the Management of Asthma (GEMA). Archivos de Bronconeumología, 53, 443-449. https://doi.org/10.1016/j.arbres.2017.04.002 |
[12] | 曾子航, 李荷蕊, 戴中上, 等. 呼出气一氧化氮分析在慢性阻塞性肺疾病中的研究进展[J]. 中国医学前沿杂志(电子版), 2019, 11(1): 30-35. |
[13] | Dweik, R.A., Boggs, P.B., Er-zurum, S.C., et al. (2011) An Official ATS Clinical Practice Guideline: Interpretation of Exhaled Nitric Oxide Levels (FENO) for Clinical Applications. American Journal of Respiratory and Critical Care Medicine, 184, 602-615. https://doi.org/10.1164/rccm.9120-11ST |
[14] | Zhang, C., Zhang, M., Wang, Y., et al. (2022) Diagnostic Value of Fractional Exhaled Nitric Oxide in Differentiating the Asthma-COPD Overlap from COPD: A Systematic Review and Meta-Analysis. Expert Review of Respiratory Medicine, 16, 679-687. https://doi.org/10.1080/17476348.2022.2011221 |
[15] | 付群, 郭迪, 赵文飞. 哮喘-慢阻肺重叠、哮喘和慢性阻塞性肺疾病患者诱导痰VEGF、ICAM-1、IL-13、呼出气一氧化氮水平的变化及临床意义[J]. 临床荟萃, 2021, 36(6): 513-516. |
[16] | 赵爽, 徐建华, 王导新, 等. 呼出气一氧化氮联合激活蛋白A测定对哮喘-慢性阻塞性肺疾病重叠的诊断价值[J]. 医学综述, 2020, 26(8): 1608-1613. |
[17] | 蒋盛荣. 慢性阻塞性肺疾病患者呼出气一氧化氮浓度变化及其临床意义[J]. 临床医药文献电子杂志, 2017, 4(A2): 20068. |
[18] | 黄叶, 蒋华, 蒋忠. AECOPD和急性稳定期COPD患者呼出气一氧化氮水平与炎症及肺功能相关性研究[J]. 河北医药, 2022, 44(14): 2129-2132. |
[19] | 刘冬, 许西琳, 辛雯艳, 等. 慢性阻塞性肺疾病患者CAT评分、呼出气一氧化氮、肺功能之间的相关性研究[J]. 吉林医学, 2017, 38(5): 831-835. |
[20] | Antus, B. and Barta, I. (2013) Relationship between Exhaled Nitric Oxide and the Frequency of Severe Acute Exacerbation of COPD: 3-Year Follow-Up. Acta Physiologica Hungarica, 100, 469-477.
https://doi.org/10.1556/APhysiol.100.2013.016 |
[21] | Alcazar-Navarrete, B., Castellano, M.F., Santiago, D.P., et al. (2018) Alveolar and Bronchial Nitric Oxide in Chronic Obstructive Pulmonary Disease and Asthma-COPD Overlap. Archivos de Bronconeumología (English Edition), 54, 414-419. https://doi.org/10.1016/j.arbr.2018.06.007 |
[22] | Cataldo, D., Corhay, J.L., Derom, E., et al. (2017) A Belgian Sur-vey on the Diagnosis of Asthma-COPD Overlap Syndrome. International Journal of Chronic Obstructive Pulmonary Disease, 12, 601-613.
https://doi.org/10.2147/COPD.S124459 |
[23] | Sin, D.D., Miravitlles, M., Mannino, D.M., et al. (2016) What Is Asthma-COPD Overlap Syndrome? Towards a Consensus Definition from a Round Table Discussion. European Res-piratory Journal, 48, 664-673.
https://doi.org/10.1183/13993003.00436-2016 |
[24] | Gibson, P.G. and Simpson, J.L. (2009) The Overlap Syndrome of Asthma and COPD: What Are Its Features and How Important Is It? Thorax, 64, 728-735. https://doi.org/10.1136/thx.2008.108027 |
[25] | Sacks, D., Baxter, B., Campbell, B., et al. (2018) Multisociety Con-sensus Quality Improvement Revised Consensus Statement for Endovascular Therapy of Acute Ischemic Stroke. Inter-national Journal of Stroke, 13, 612-632.
https://doi.org/10.1016/j.jvir.2017.11.026 |
[26] | 陈嘉琦, 肖婉媚, 陈翠仪. 支气管哮喘—慢性阻塞性肺疾病重叠患者呼出气一氧化氮与肺功能及血生化指标的关系[J]. 医学理论与实践, 2022, 35(20): 3421-3424. |
[27] | Kobayashi, S., Hanagama, M., Yamanda, S., et al. (2016) Inflammatory Biomarkers in Asthma-COPD Overlap Syndrome. International Journal of Chronic Obstructive Pulmonary Disease, 11, 2117-2123.
https://doi.org/10.2147/COPD.S113647 |
[28] | Chen, F.J., Huang, X.Y., Liu, Y.L., et al. (2016) Importance of Frac-tional Exhaled Nitric Oxide in the Differentiation of Asthma-COPD Overlap Syndrome, Asthma, and COPD. Interna-tional Journal of Chronic Obstructive Pulmonary Disease, 11, 2385-2390. https://doi.org/10.2147/COPD.S115378 |
[29] | Takayama, Y., Ohnishi, H., Ogasawara, F., et al. (2018) Clinical Utility of Fractional Exhaled Nitric Oxide and Blood Eosinophils Counts in the Diagnosis of Asthma-COPD Overlap. International Journal of Chronic Obstructive Pulmonary Disease, 13, 2525-2532. https://doi.org/10.2147/COPD.S167600 |
[30] | 陈晓蛟, 王浩杰. 呼出气一氧化氮对哮喘-COPD重叠综合征的诊疗价值[J]. 临床医药文献电子杂志, 2018, 5(6): 29-30. |
[31] | Roman-Rodriguez, M. and Kaplan, A. (2021) GOLD 2021 Strategy Report: Implications for Asthma-COPD Overlap. International Journal of Chronic Obstructive Pulmo-nary Disease, 16, 1709-1715.
https://doi.org/10.2147/COPD.S300902 |
[32] | 王述红, 何正光, 罗晓斌, 等. 呼出气一氧化氮测定对不同急性加重频率慢性阻塞性肺疾病表型治疗效果的预测作用[J]. 中国呼吸与危重监护杂志, 2020, 19(5): 435-440. |
[33] | Li, Q., Larivee, P., Courteau, J., et al. (2018) Greater Eosinophil Counts at First COPD Hospitalization Are Associated with More Readmissions and Fewer Deaths. International Journal of Chronic Obstructive Pulmonary Disease, 14, 331-341. https://doi.org/10.2147/COPD.S187375 |